NYSE:ABBVBiotechs
Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness
What AbbVie’s Recent Performance Tells You Right Now
AbbVie (ABBV) has drawn investor attention after a period of weaker share performance, with the stock showing declines over the past week, month, and past 3 months despite a positive 1 year total return.
See our latest analysis for AbbVie.
Short term momentum has cooled, with a 1 day share price return of 2.52% decline and a 30 day share price return of 5.11% decline, even though AbbVie’s 5 year total shareholder return of 157.21% reflects...